These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16723230)

  • 21. Sporadic rippling muscle disease unmasked by simvastatin.
    Baker SK; Tarnopolsky MA
    Muscle Nerve; 2006 Oct; 34(4):478-81. PubMed ID: 16688722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Myofibrillar myopathies: another complex myopathic syndrome].
    Olivé M; Ferrer I
    Neurologia; 2001 May; 16(5):191-4. PubMed ID: 11412717
    [No Abstract]   [Full Text] [Related]  

  • 23. Caveolin-3 gene mutation in Japanese with rippling muscle disease.
    Yabe I; Kawashima A; Kikuchi S; Higashi T; Fukazawa T; Hamada T; Sasaki H; Tashiro K
    Acta Neurol Scand; 2003 Jul; 108(1):47-51. PubMed ID: 12807393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel in-frame deletion in the CAV3 gene in a Korean patient with rippling muscle disease.
    Bae JS; Ki CS; Kim JW; Suh YL; Park MS; Kim BJ; Kim SJ
    J Neurol Sci; 2007 Sep; 260(1-2):275-8. PubMed ID: 17524427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition.
    Ohsawa Y; Hagiwara H; Nakatani M; Yasue A; Moriyama K; Murakami T; Tsuchida K; Noji S; Sunada Y
    J Clin Invest; 2006 Nov; 116(11):2924-34. PubMed ID: 17039257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rippling is not always electrically silent in rippling muscle disease.
    Maki T; Matsumoto R; Kohara N; Kondo T; Son I; Mezaki T; Nishino I; Ikeda A; Takahashi R
    Muscle Nerve; 2011 Apr; 43(4):601-5. PubMed ID: 21404291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel missense mutation in the caveolin-3 gene in a Belgian family with rippling muscle disease.
    Van den Bergh PY; Gérard JM; Elosegi JA; Manto MU; Kubisch C; Schoser BG
    J Neurol Neurosurg Psychiatry; 2004 Sep; 75(9):1349-51. PubMed ID: 15314133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Muscle stiffness and muscle pain.
    Klawans HL; Weiner WJ
    Clin Ther; 1981; 4(2):62-72. PubMed ID: 7296595
    [No Abstract]   [Full Text] [Related]  

  • 29. Differential effects of myopathy-associated caveolin-3 mutants on growth factor signaling.
    Brauers E; Dreier A; Roos A; Wormland B; Weis J; Krüttgen A
    Am J Pathol; 2010 Jul; 177(1):261-70. PubMed ID: 20472890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation.
    Vorgerd M; Ricker K; Ziemssen F; Kress W; Goebel HH; Nix WA; Kubisch C; Schoser BG; Mortier W
    Neurology; 2001 Dec; 57(12):2273-7. PubMed ID: 11756609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of caveolin-3 induced by the dystrophy-associated P104L mutation impairs L-type calcium channel function in mouse skeletal muscle cells.
    Couchoux H; Allard B; Legrand C; Jacquemond V; Berthier C
    J Physiol; 2007 May; 580(Pt.3):745-54. PubMed ID: 17317753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sarcoplasmic hexagonally cross-linked tubular arrays immunostain for caveolin-3: an excess caveolinopathy?
    Lach B; Tarnopolsky M; Nguyen C
    Acta Neuropathol; 2009 Mar; 117(3):339-41. PubMed ID: 19184067
    [No Abstract]   [Full Text] [Related]  

  • 33. CAV3 T78M mutation as polymorphic variant in South Italy.
    Spadafora P; Liguori M; Andreoli V; Quattrone A; Gambardella A
    Neuromuscul Disord; 2012 Jul; 22(7):669-70; author reply 670-1. PubMed ID: 22595201
    [No Abstract]   [Full Text] [Related]  

  • 34. Symptomatic dysferlin gene mutation carriers: characterization of two cases.
    Illa I; De Luna N; Domínguez-Perles R; Rojas-García R; Paradas C; Palmer J; Márquez C; Gallano P; Gallardo E
    Neurology; 2007 Apr; 68(16):1284-9. PubMed ID: 17287450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bedside diagnosis of rippling muscle disease.
    Wiwanitkit V
    Muscle Nerve; 2011 Jan; 43(1):144; author reply 144. PubMed ID: 21082690
    [No Abstract]   [Full Text] [Related]  

  • 36. Rippling muscle disease.
    Ricker K; Moxley RT; Rohkamm R
    Arch Neurol; 1989 Apr; 46(4):405-8. PubMed ID: 2705900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 'Stiff-man syndrome' in an adolescent.
    Daras M; Spiro AJ
    Pediatrics; 1981 May; 67(5):725-6. PubMed ID: 7255004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of caveolar components in primary desminopathy.
    Shinde A; Nakano S; Sugawara M; Toyoshima I; Ito H; Tanaka K; Kusaka H
    Neuromuscul Disord; 2008 Mar; 18(3):215-9. PubMed ID: 18343114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rippling muscle syndrome.
    Arimura K
    Intern Med; 2002 May; 41(5):325-6. PubMed ID: 12058874
    [No Abstract]   [Full Text] [Related]  

  • 40. An integrated approach to the diagnosis of muscle disorders: what is the role of muscle imaging?
    Mercuri E
    Dev Med Child Neurol; 2010 Aug; 52(8):693. PubMed ID: 20653735
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.